Proactive Investors - Run By Investors For Investors

Sativa Investments to open first of three cannabidiol wellness centres in Bath

“Goodbody & Blunt's high-street CBD outlets will break with tradition, delivering high-end wellness centres with fully trained staff to advise on the quality and provenance of products," said chief executive Geremy Thomas.
The store will include a café for customers to consume CBD infused tea, coffee and water

Sativa Investments PLC (NEX:SATI) is to open its first Goodbody & Blunt cannabidiol (CBD) wellness centre in Bath.

The UK medicinal cannabis investment vehicle said the store will include a café for customers to consume CBD infused tea, coffee and water.

READ: Sativa Investments teams up with King's College London to research cannabinoids for medicinal use

Customers will be able to buy CBD sports energy shots and take home CBD coffee beans and tea bags.

The store will stock cannabis products from its George Botanicals business and other brands from around the world.

The group said it has leased a 60.67 square metre retail unit with frontage on the Broad Street and Milson Place City-centre shopping destinations. 

The store is expected to open in early summer.

It is the first of three pilot stores that Sativa intends to open before rolling out a national franchise network.

"Sativa was first to market as a UK-quoted medical cannabis investment vehicle and continues to lead the way with its seed to consumer strategy,” said chief executive Geremy Thomas.

“Goodbody & Blunt's high-street CBD outlets will break with tradition, delivering high-end wellness centres with fully trained staff to advise on the quality and provenance of products.” 

Sativa said every item stocked in the Goodbody & Blunt stores will have passed rigorous industry-leading tests, conducted by its own PhytoVista Laboratories.

CBD is a compound found in the cannabis plant that is non-psychoactive and can be well tolerated, as opposed to tetrahydrocannabinol (THC) – the psychoactive cannabinoid that gets a user “high”.

For this reason, the substance can be sold in the UK without a licence so long as it is not marketed as a medicinal product. CBD is widely available at retailers as an oil, spray or food supplement.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full SATI profile View Profile

Sativa Group PLC Timeline

Related Articles

LX2 analyzer
May 07 2019
Armed with promising study results and proven technology, LexaGene is getting ready to launch the LX2 Genetic Analyzer to underserved markets valued at an estimated US$40 billion
June 07 2019
Geremy Thomas, founder and chief executive of Sativa, said the company has "delivered expeditiously on its investment promise to the market"
April 30 2019
We take a look at a company with a unique approach to drug development that may ultimately help big pharma replenish its pipeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use